JAZZ

NASDAQ 已收盘

Jazz Pharmaceuticals

236.45 USD
▼-11.32-4.57%
盘后 240.35 0.00%
2026-11-19
市值
$14.91B
市盈率
74.97
EPS
3.10
股息率
—
52 周区间
156.95 – 266.38
成交量
1.44M
Beta
0.37
目标价
297.50
52W 低 156.9552W 高 266.38
价格走势

公司简介

Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally. The company offers Xywav to treat cataplexy or excessive daytime sleepiness (EDS) with narcolepsy and idiopathic hypersomnia (IH); Epidiolex for seizures associated with Lennox-Gastaut syndrome (LGS), Dravet syndrome (DS), or tuberous sclerosis complex (TSC); Rylaze for the treatment of acute lymphoblastic leukemia or lymphoblastic lymphoma; Enrylaze to treat acute lymphoblastic leukemia and lymphoblastic ...

关联新闻